Idiopathic Mixed Cryoglobulinemia: A New Therapeutic Approach with Alpha Interferon
暂无分享,去创建一个
L. Bonomo | A. Afeltra | M. Casato | D. Caccavo | F. Vaccaro | L. Ercoli | Siena Mm
[1] C. Nathan,et al. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.
[2] I. Gresser,et al. Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X‐ray‐transformed C3H/10T1/2 cells under prolonged treatment with interferon , 1981, International journal of cancer.
[3] J. Clauvel,et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.
[4] I. Gresser,et al. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Meltzer,et al. Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. , 1966, The American journal of medicine.
[6] J. D. Marshall,et al. γ-Interferon is one of several direct B cell-maturing lymphokines , 1984, Nature.
[7] E. Saksela. [Interferon and natural killer cells]. , 1980, Duodecim; laaketieteellinen aikakauskirja.